1. Home
  2. ONMD vs COEP Comparison

ONMD vs COEP Comparison

Compare ONMD & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONMD
  • COEP
  • Stock Information
  • Founded
  • ONMD 2006
  • COEP 2017
  • Country
  • ONMD United States
  • COEP United States
  • Employees
  • ONMD N/A
  • COEP N/A
  • Industry
  • ONMD
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ONMD
  • COEP Health Care
  • Exchange
  • ONMD Nasdaq
  • COEP Nasdaq
  • Market Cap
  • ONMD 32.5M
  • COEP 32.4M
  • IPO Year
  • ONMD N/A
  • COEP N/A
  • Fundamental
  • Price
  • ONMD $1.02
  • COEP $9.21
  • Analyst Decision
  • ONMD
  • COEP
  • Analyst Count
  • ONMD 0
  • COEP 0
  • Target Price
  • ONMD N/A
  • COEP N/A
  • AVG Volume (30 Days)
  • ONMD 149.4K
  • COEP 188.6K
  • Earning Date
  • ONMD 12-17-2024
  • COEP 03-25-2025
  • Dividend Yield
  • ONMD N/A
  • COEP N/A
  • EPS Growth
  • ONMD N/A
  • COEP N/A
  • EPS
  • ONMD 0.01
  • COEP N/A
  • Revenue
  • ONMD $957,651.00
  • COEP N/A
  • Revenue This Year
  • ONMD N/A
  • COEP N/A
  • Revenue Next Year
  • ONMD N/A
  • COEP N/A
  • P/E Ratio
  • ONMD $123.77
  • COEP N/A
  • Revenue Growth
  • ONMD 1.36
  • COEP N/A
  • 52 Week Low
  • ONMD $0.46
  • COEP $2.31
  • 52 Week High
  • ONMD $3.37
  • COEP $13.70
  • Technical
  • Relative Strength Index (RSI)
  • ONMD 41.30
  • COEP 63.66
  • Support Level
  • ONMD $1.06
  • COEP $10.05
  • Resistance Level
  • ONMD $1.06
  • COEP $13.70
  • Average True Range (ATR)
  • ONMD 0.11
  • COEP 1.83
  • MACD
  • ONMD -0.03
  • COEP -0.02
  • Stochastic Oscillator
  • ONMD 4.17
  • COEP 68.67

About ONMD OneMedNet Corp

OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a global provider of clinical imaging innovation and curator of regulatory-grade Imaging Real-World Data or iRWDTM. OneMedNet's innovative solutions connect healthcare providers and patients satisfying a crucial need within the Life Sciences field offering direct access to clinical images and the associated contextual patient record.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Share on Social Networks: